CONMED Corporation - Common Stock (CNMD)

CONMED’s third quarter reflected stability in its core business, with year-over-year sales holding flat and revenue meeting Wall Street’s expectations. Manag...

Medical tech company CONMED (NYSE:CNMD) met Wall Street’s revenue expectations in Q3 2026, but sales were flat year on year at $335.6 million. The company’s ...

CONMED (NYSE:CNMD) reported third-quarter 2026 revenue of $335.6 million, with organic constant-currency sales growth of 6.7% as the medical technology company cited broad-based contributions from its general surgery and orthopedic surgery businesses. Reported net sales declined 0.7%, or 0.8% on a

International surgical sales surged double digits amid domestic restructuring headwinds.

Medical tech company CONMED (NYSE:CNMD) met Wall Street’s revenue expectations in Q3 2026, but revenue was flat year on year at $335.6 million. The company’s...

Medical tech company CONMED (NYSE:CNMD) will be reporting earnings this Wednesday after the bell. Here’s what you need to know. CONMED beat analysts’ revenue...

A stock with low volatility can be reassuring, but it doesn’t always mean strong long-term performance. Investors who prioritize stability may miss out on hi...

Looking back on surgical equipment & consumables - diversified stocks’ Q2 earnings, we examine this quarter’s best and worst performers, including CONMED (NY...

Value stocks typically trade at discounts to the broader market, offering patient investors the opportunity to buy businesses when they’re out of favor. The ...

Wall Street has issued downbeat forecasts for the stocks in this article. These predictions are rare - financial institutions typically hesitate to say bad t...

As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q2. Today, we are looking a...

CONMED has followed the market’s trajectory closely, rising in tandem with the S&P 500 over the past six months. The stock has climbed by 11% to $51.11 per s...

Check out the companies making headlines this week: Huron (NASDAQ:HURN): Professional services firm Huron Consulting Group (NASDAQ:HURN) rose by 35.8% on Wed...

What Happened? Shares of medical tech company CONMED (NYSE:CNMD) jumped 10.5% in the afternoon session after the company reported second-quarter adjusted ear...

CONMED (NYSE:CNMD) reported second-quarter 2026 net sales of $343.5 million, up 0.3% on a reported basis but down 0.5% in constant currency. Organic sales, which exclude the company’s exited gastroenterology product offerings, rose 6% year over year and modestly exceeded management’s expectations.

Medical tech company CONMED (NYSE:CNMD) reported revenue ahead of Wall Street’s expectations in Q2 CY2026, but sales were flat year on year at $343.5 million...

Medical tech company CONMED (NYSE:CNMD) will be reporting results this Wednesday after market close. Here’s what investors should know. CONMED beat analysts’...

The Russell 2000 (^RUT) is packed with potential breakout stocks, thanks to its focus on smaller companies with high growth potential. However, smaller size ...

What Happened? Shares of medical tech company CONMED (NYSE:CNMD) jumped 9% in the afternoon session after reports revealed the company is exploring a potenti...

Personal health and wellness is one of the many secular tailwinds for healthcare companies. Shareholders who bet on the industry have been rewarded lately as...

Value investing has produced some of the world’s most famous investing billionaires, including Warren Buffett, David Einhorn, and Seth Klarman, who built the...

Stocks trading between $10 and $50 can be particularly interesting as they frequently represent businesses that have survived their early challenges. However...